We hypothesize that βB2-crystallin contributes to poor diagnosis in malignancies such as breast and prostate cancer through regulating the TGF-β pathway or WNT signaling pathway and promoting epithelial to mesenchymal transition (EMT) [27, 116]. This evidence concerns the gene TGFB1 and prostate cancer.